Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes.

This measure expresses support for making testing for antiphospholipid syndrome (APS) a standard part of prenatal screening. APS is a condition that can affect pregnancy. The resolution states support for including APS testing during routine prenatal care .

Key points

• What it does: Expresses support for adding APS testing to prenatal screening; it does not set specific rules or requirements in the text provided .
• Who is touched by this: People receiving prenatal screening and their care teams, in the context of pregnancy and prenatal care .
• When: Timing or deadlines are not specified in the text provided .